RESET
AssetAlso RESET System, RESET Liner
Endoluminal duodenal bypass liner device for glycemic improvement and weight management
- Stage
- Human trials
- Modality
- Device
- Target
- Insulin/IGF-1 signalling
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Diabetes type2
Human trials, Recruiting, NCT04101669, clinicaltrials.gov, 7 Oct 2026
Obesity
Human trials, Recruiting, NCT04101669, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.